These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9771206)

  • 21. [D-penicillamine in the treatment of progressive systemic sclerosis].
    Marques Neto JF; Manzato LC; Samara AM
    AMB Rev Assoc Med Bras; 1980 Jun; 26(6):191-3. PubMed ID: 6970374
    [No Abstract]   [Full Text] [Related]  

  • 22. Asymptomatic annular plaques on the neck.
    Chabra IS; Grandinetti LM
    Cutis; 2014 Oct; 94(4):E1-3. PubMed ID: 25372260
    [No Abstract]   [Full Text] [Related]  

  • 23. [Two cases of successfully treated multifocal fibrosis].
    Guseva NG; Nevskaia TA; Starovoĭtova MN
    Ter Arkh; 2002; 74(5):77-9. PubMed ID: 12087915
    [No Abstract]   [Full Text] [Related]  

  • 24. Penicillamine in systemic sclerosis: a reappraisal.
    Sattar MA; Guindi RT; Sugathan TN
    Clin Rheumatol; 1990 Dec; 9(4):517-22. PubMed ID: 2088649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment.
    Bluestone R; Grahame R; Holloway V; Holt PJ
    Ann Rheum Dis; 1970 Mar; 29(2):153-8. PubMed ID: 5427411
    [No Abstract]   [Full Text] [Related]  

  • 26. D-penicillamine is not an effective treatment in systemic sclerosis.
    Furst DE; Clements PJ
    Scand J Rheumatol; 2001; 30(4):189-91. PubMed ID: 11578010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of progressive systemic sclerosis (PSS) with penicillamine. Preliminary report of two cases.
    Tio H; van Wijk L; de Haan E
    Acta Med Scand; 1973 May; 193(5):477-80. PubMed ID: 4717327
    [No Abstract]   [Full Text] [Related]  

  • 28. [Penicillamine in the treatment of scleroderma].
    Kobíková M; Stáva Z
    Cesk Dermatol; 1973 Dec; 48(6):408-10. PubMed ID: 4771784
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trials for pediatric scleroderma.
    Rosenkranz ME; Lehman TJ
    Curr Rheumatol Rep; 2002 Dec; 4(6):449-51. PubMed ID: 12427357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Progressive systemic sclerosis with pancytopenia, polymyositis and complete heart block developing after D-penicillamine therapy: a case report].
    Matsumura T; Kabashima T; Kono I; Yamane K; Sakurai T; Yamaguchi I; Kashiwagi H
    Nihon Naika Gakkai Zasshi; 1985 Jul; 74(7):958-63. PubMed ID: 4056558
    [No Abstract]   [Full Text] [Related]  

  • 31. Penicillamine-induced polymyositis.
    Leden I; Libelius R
    Scand J Rheumatol; 1985; 14(1):90-3. PubMed ID: 4001884
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic effect of d-penicillamine in scleroderma].
    Bogdanikowa B; Rudy J; Bernacka K; Palka Z
    Pol Tyg Lek; 1973 Aug; 28(34):1317-20. PubMed ID: 4756401
    [No Abstract]   [Full Text] [Related]  

  • 33. D-penicillamine induced polymyositis causing complete heart block.
    Wright GD; Wilson C; Bell AL
    Clin Rheumatol; 1994 Mar; 13(1):80-2. PubMed ID: 8187449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of progressive scleroderma with D-penicillamine (Metalcaptase)].
    Böni A; Pavelka K; Kludas M
    Munch Med Wochenschr; 1969 Aug; 111(31):1580-4. PubMed ID: 5394493
    [No Abstract]   [Full Text] [Related]  

  • 35. Vesicular lesions in a woman with progressive systemic sclerosis. Penicillamine-induced intradermal vesicles: an example of human lathyrism.
    Godar JM; Norins AL
    Arch Dermatol; 1992 Jul; 128(7):977-8, 980-1. PubMed ID: 1626968
    [No Abstract]   [Full Text] [Related]  

  • 36. [Extra-capillary glomerulonephritis induced by D-penicillamine therapy].
    Marlier S; Gisserot O; Yao N; Hecht M; Paris JF; Carli P; Chagnon A
    Presse Med; 1999 Apr; 28(13):689-90. PubMed ID: 10228478
    [No Abstract]   [Full Text] [Related]  

  • 37. [Marked proteinuria in the course of penicillamine treatment of progressive systemic sclerosis].
    Filipecki S; Dabrowska B; Szczepański A; Glyda J
    Pol Tyg Lek; 1971 Nov; 26(46):1780-1. PubMed ID: 5131995
    [No Abstract]   [Full Text] [Related]  

  • 38. Polymyositis due to D-penicillamine in a patient with systemic sclerosis.
    Santos JC; Velasco JA
    Clin Exp Dermatol; 1991 Jan; 16(1):76. PubMed ID: 2025947
    [No Abstract]   [Full Text] [Related]  

  • 39. Penicillamine for scleroderma.
    Fulghum DD; Katz R
    Arch Dermatol; 1968 Jul; 98(1):51-2. PubMed ID: 5241672
    [No Abstract]   [Full Text] [Related]  

  • 40. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
    Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
    Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.